Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical, Cosmetic and Investigational Dermatology|September 18, 2023
A Neglected Narrative in the COVID-19 Pandemic: Epidemiological and Clinical Impacts of the COVID-19 Outbreak on SyphilisMingjuan Liu, Jia Zhou, Yining Lan, et al.
International Immunopharmacology|October 3, 2025
Emerging role of Itaconate in inflammatory bowel disease: From multitarget Immunometabolic mechanisms to therapeutic translationMei Kang, Daiyuan Tang, Wei Huang, et al.
Medicine|March 18, 2025
The global, regional, and national burdens of dementia in 204 countries and territories from 1990 to 2021: A trend analysis based on the Global Burden of Disease Study 2021Songxin Zhong, Chao Xiao, Rida Li, et al.
International Immunopharmacology|June 8, 2026
Smartly engineered biomaterials drive immune remodeling: A new paradigm for precise treatment of inflammatory bowel diseaseShitong Liu, Daiyuan Tang, Mei Kang, et al.
Archives of Dermatological Research|September 29, 2023
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019Mingjuan Liu, Mengyin Wu, Xintong Liu, et al.
Aesthetic Plastic Surgery|May 6, 2025
Advancing Preoperative Planning in Perforator Flap Surgery with Photon-Counting Computed Tomography Angiography: Less Challenges with More PrecisionYining Lan, Runzhu Liu, Luqi Guo, et al.
Infection and Drug Resistance|November 6, 2023
Clinical and Laboratory Characteristics, Neuroimaging Alternations and Treatment Response of 25 HIV-Negative General Paresis PatientsMingjuan Liu, Meiyi Tong, Jia Zhou, et al.
Melanoma Research|August 31, 2023
Telomere length is associated with increased risk of cutaneous melanoma: a Mendelian randomization studyMingjuan Liu, Yining Lan, Hanlin Zhang, et al.
The ISME Journal|February 16, 2026
Gut microbial production of lithocholic acid reprograms pro-resolutive macrophages to enhance vedolizumab responsiveness via the TGR5/FXR-NF-κB axisBing Han, Hongtao Wen, Ya Li, et al.
Pageof 2